Intervention in autoimmunity: The potential of vitamin D receptor agonists
- 1 February 2005
- journal article
- review article
- Published by Elsevier in Cellular Immunology
- Vol. 233 (2) , 115-124
- https://doi.org/10.1016/j.cellimm.2005.04.013
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Gene expression analysis suggests that 1,25-dihydroxyvitamin D3reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosisPhysiological Genomics, 2004
- Pharmacological induction of tolerogenic dendritic cells and regulatory T cellsSeminars in Immunology, 2004
- Pharmacologic, biologic, and genetic engineering approaches to potentiation of donorderived dendritic cell tolerogenicity1Transplantation, 2003
- The balance of Th1/Th2 cytokines in rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2001
- Highly active analogs of 1α,25-dihydroxyvitamin D3 that resist metabolism through C-24 oxidation and C-3 epimerization pathwaysSteroids, 2001
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Potent Inhibition of Dendritic Cell Differentiation and Maturation by Vitamin D AnalogsBiochemical and Biophysical Research Communications, 2000
- Effect of calcitriol on the production of T-cell-derived cytokines in psoriasisBritish Journal of Dermatology, 1997
- Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)Clinical and Experimental Immunology, 1995
- 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD miceDiabetes, 1992